EMEA (Europe, Middle East and Africa) Anticoagulants Market Report 2017

December 2017 | 112 pages | ID: E12947B53DCEN
QYResearch

Abstracts

In this report, the EMEA Anticoagulants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Anticoagulants for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Anticoagulants market competition by top manufacturers/players, with Anticoagulants sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi
• Bayer
• Boehringer Ingelheim
• Johnson & Johnson
• Genentech (Roche)
• AstraZeneca
• Bristol-Myers Squibb
• Aspen
• Lilly
• Otsuka
• Pfizer
• Daiichi Sankyo
• The Medicines Company

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Platelet aggregation inhibitors (PAI)
• Low-molecular-weight Heparin (LMWH)
• Direct thrombin inhibitor (DTI)
• Direct factor Xa inhibitors (DFXa)
• Vitamin K antagonists (VKA)
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• VTE
• ACS/MI
• AF
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Anticoagulants Market Report 2017

1 ANTICOAGULANTS OVERVIEW

1.1 Product Overview and Scope of Anticoagulants
1.2 Classification of Anticoagulants
  1.2.1 EMEA Anticoagulants Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Anticoagulants Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Platelet aggregation inhibitors (PAI)
  1.2.4 Low-molecular-weight Heparin (LMWH)
  1.2.5 Direct thrombin inhibitor (DTI)
  1.2.6 Direct factor Xa inhibitors (DFXa)
  1.2.7 Vitamin K antagonists (VKA)
  1.2.8 Others
1.3 EMEA Anticoagulants Market by Application/End Users
  1.3.1 EMEA Anticoagulants Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 VTE
  1.3.3 ACS/MI
  1.3.4 AF
  1.3.5 Other
1.4 EMEA Anticoagulants Market by Region
  1.4.1 EMEA Anticoagulants Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Anticoagulants (2012-2022)
  1.5.1 EMEA Anticoagulants Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Anticoagulants Revenue and Growth Rate (2012-2022)

2 EMEA ANTICOAGULANTS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Anticoagulants Market Competition by Players/Manufacturers
  2.1.1 EMEA Anticoagulants Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Anticoagulants Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Anticoagulants Sale Price by Players (2012-2017)
2.2 EMEA Anticoagulants (Volume and Value) by Type/Product Category
  2.2.1 EMEA Anticoagulants Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Anticoagulants Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Anticoagulants Sale Price by Type (2012-2017)
2.3 EMEA Anticoagulants (Volume) by Application
2.4 EMEA Anticoagulants (Volume and Value) by Region
  2.4.1 EMEA Anticoagulants Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Anticoagulants Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Anticoagulants Sales Price by Region (2012-2017)

3 EUROPE ANTICOAGULANTS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Anticoagulants Sales and Value (2012-2017)
  3.1.1 Europe Anticoagulants Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Anticoagulants Revenue and Growth Rate (2012-2017)
3.2 Europe Anticoagulants Sales and Market Share by Type
3.3 Europe Anticoagulants Sales and Market Share by Application
3.4 Europe Anticoagulants Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Anticoagulants Sales Volume by Countries (2012-2017)
  3.4.2 Europe Anticoagulants Revenue by Countries (2012-2017)
  3.4.3 Germany Anticoagulants Sales and Growth Rate (2012-2017)
  3.4.4 France Anticoagulants Sales and Growth Rate (2012-2017)
  3.4.5 UK Anticoagulants Sales and Growth Rate (2012-2017)
  3.4.6 Russia Anticoagulants Sales and Growth Rate (2012-2017)
  3.4.7 Italy Anticoagulants Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Anticoagulants Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ANTICOAGULANTS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Anticoagulants Sales and Value (2012-2017)
  4.1.1 Middle East Anticoagulants Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Anticoagulants Revenue and Growth Rate (2012-2017)
4.2 Middle East Anticoagulants Sales and Market Share by Type
4.3 Middle East Anticoagulants Sales and Market Share by Application
4.4 Middle East Anticoagulants Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Anticoagulants Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Anticoagulants Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Anticoagulants Sales and Growth Rate (2012-2017)
  4.4.4 Israel Anticoagulants Sales and Growth Rate (2012-2017)
  4.4.5 UAE Anticoagulants Sales and Growth Rate (2012-2017)
  4.4.6 Iran Anticoagulants Sales and Growth Rate (2012-2017)

5 AFRICA ANTICOAGULANTS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Anticoagulants Sales and Value (2012-2017)
  5.1.1 Africa Anticoagulants Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Anticoagulants Revenue and Growth Rate (2012-2017)
5.2 Africa Anticoagulants Sales and Market Share by Type
5.3 Africa Anticoagulants Sales and Market Share by Application
5.4 Africa Anticoagulants Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Anticoagulants Sales Volume by Countries (2012-2017)
  5.4.2 Africa Anticoagulants Revenue by Countries (2012-2017)
  5.4.3 South Africa Anticoagulants Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Anticoagulants Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Anticoagulants Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Anticoagulants Sales and Growth Rate (2012-2017)

6 EMEA ANTICOAGULANTS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Anticoagulants Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Anticoagulants Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Boehringer Ingelheim
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Anticoagulants Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Boehringer Ingelheim Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Anticoagulants Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Johnson & Johnson Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Genentech (Roche)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Anticoagulants Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Genentech (Roche) Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AstraZeneca
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Anticoagulants Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AstraZeneca Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bristol-Myers Squibb
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Anticoagulants Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bristol-Myers Squibb Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Aspen
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Anticoagulants Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Aspen Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Lilly
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Anticoagulants Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Lilly Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Otsuka
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Anticoagulants Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Otsuka Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Pfizer
6.12 Daiichi Sankyo
6.13 The Medicines Company

7 ANTICOAGULANTS MANUFACTURING COST ANALYSIS

7.1 Anticoagulants Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anticoagulants

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Anticoagulants Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anticoagulants Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ANTICOAGULANTS MARKET FORECAST (2017-2022)

11.1 EMEA Anticoagulants Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Anticoagulants Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Anticoagulants Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Anticoagulants Price and Trend Forecast (2017-2022)
11.2 EMEA Anticoagulants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Anticoagulants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Anticoagulants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Anticoagulants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Anticoagulants Sales Forecast by Type (2017-2022)
11.7 EMEA Anticoagulants Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Anticoagulants
Figure EMEA Anticoagulants Sales Volume (Units) by Type (2012-2022)
Figure EMEA Anticoagulants Sales Volume Market Share by Type (Product Category) in 2016
Figure Platelet aggregation inhibitors (PAI) Product Picture
Figure Low-molecular-weight Heparin (LMWH) Product Picture
Figure Direct thrombin inhibitor (DTI) Product Picture
Figure Direct factor Xa inhibitors (DFXa) Product Picture
Figure Vitamin K antagonists (VKA) Product Picture
Figure Others Product Picture
Figure EMEA Anticoagulants Sales Volume (Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Anticoagulants by Application in 2016
Figure VTE Examples
Table Key Downstream Customer in VTE
Figure ACS/MI Examples
Table Key Downstream Customer in ACS/MI
Figure AF Examples
Table Key Downstream Customer in AF
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Anticoagulants Market Size (Million USD) by Region (2012-2022)
Figure Europe Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Anticoagulants Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Anticoagulants Revenue (Million USD) Status and Forecast by Countries
Figure Africa Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Anticoagulants Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Anticoagulants Sales Volume and Growth Rate (2012-2022)
Figure EMEA Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Anticoagulants Market Major Players Product Sales Volume (Units) (2012-2017)
Table EMEA Anticoagulants Sales Volume (Units) of Major Players (2012-2017)
Table EMEA Anticoagulants Sales Share by Players (2012-2017)
Figure 2016 Anticoagulants Sales Share by Players
Figure 2017 Anticoagulants Sales Share by Players
Figure EMEA Anticoagulants Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Anticoagulants Revenue (Million USD) by Players (2012-2017)
Table EMEA Anticoagulants Revenue Share by Players (2012-2017)
Table 2016 EMEA Anticoagulants Revenue Share by Players
Table 2017 EMEA Anticoagulants Revenue Share by Players
Table EMEA Anticoagulants Sale Price (K USD/Unit) by Players (2012-2017)
Table EMEA Anticoagulants Sales (Units) and Market Share by Type (2012-2017)
Table EMEA Anticoagulants Sales Share by Type (2012-2017)
Figure Sales Market Share of Anticoagulants by Type (2012-2017)
Figure EMEA Anticoagulants Sales Market Share by Type (2012-2017)
Table EMEA Anticoagulants Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Anticoagulants Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anticoagulants by Type in 2016
Table EMEA Anticoagulants Sale Price (K USD/Unit) by Type (2012-2017)
Table EMEA Anticoagulants Sales (Units) and Market Share by Application (2012-2017)
Table EMEA Anticoagulants Sales Share by Application (2012-2017)
Figure Sales Market Share of Anticoagulants by Application (2012-2017)
Figure EMEA Anticoagulants Sales Market Share by Application in 2016
Table EMEA Anticoagulants Sales (Units) and Market Share by Region (2012-2017)
Table EMEA Anticoagulants Sales Share by Region (2012-2017)
Figure Sales Market Share of Anticoagulants by Region (2012-2017)
Figure EMEA Anticoagulants Sales Market Share in 2016
Table EMEA Anticoagulants Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Anticoagulants Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Anticoagulants by Region (2012-2017)
Figure EMEA Anticoagulants Revenue Market Share Regions in 2016
Table EMEA Anticoagulants Sales Price (K USD/Unit) by Region (2012-2017)
Figure Europe Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Europe Anticoagulants Revenue and Growth Rate (2012-2017)
Table Europe Anticoagulants Sales (Units) by Type (2012-2017)
Table Europe Anticoagulants Market Share by Type (2012-2017)
Figure Europe Anticoagulants Market Share by Type in 2016
Table Europe Anticoagulants Sales (Units) by Application (2012-2017)
Table Europe Anticoagulants Market Share by Application (2012-2017)
Figure Europe Anticoagulants Market Share by Application in 2016
Table Europe Anticoagulants Sales (Units) by Countries (2012-2017)
Table Europe Anticoagulants Sales Market Share by Countries (2012-2017)
Figure Europe Anticoagulants Sales Market Share by Countries (2012-2017)
Figure Europe Anticoagulants Sales Market Share by Countries in 2016
Table Europe Anticoagulants Revenue (Million USD) by Countries (2012-2017)
Table Europe Anticoagulants Revenue Market Share by Countries (2012-2017)
Figure Europe Anticoagulants Revenue Market Share by Countries (2012-2017)
Figure Europe Anticoagulants Revenue Market Share by Countries in 2016
Figure Germany Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure France Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure UK Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Russia Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Italy Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Benelux Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Middle East Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Middle East Anticoagulants Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Anticoagulants Sales (Units) by Type (2012-2017)
Table Middle East Anticoagulants Market Share by Type (2012-2017)
Figure Middle East Anticoagulants Market Share by Type (2012-2017)
Table Middle East Anticoagulants Sales (Units) by Applications (2012-2017)
Table Middle East Anticoagulants Market Share by Applications (2012-2017)
Figure Middle East Anticoagulants Sales Market Share by Application in 2016
Table Middle East Anticoagulants Sales Volume (Units) by Countries (2012-2017)
Table Middle East Anticoagulants Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Anticoagulants Sales Volume Market Share by Countries in 2016
Table Middle East Anticoagulants Revenue (Million USD) by Countries (2012-2017)
Table Middle East Anticoagulants Revenue Market Share by Countries (2012-2017)
Figure Middle East Anticoagulants Revenue Market Share by Countries (2012-2017)
Figure Middle East Anticoagulants Revenue Market Share by Countries in 2016
Figure Saudi Arabia Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Israel Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure UAE Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Iran Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Africa Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Africa Anticoagulants Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Anticoagulants Sales (Units) by Type (2012-2017)
Table Africa Anticoagulants Sales Market Share by Type (2012-2017)
Figure Africa Anticoagulants Sales Market Share by Type (2012-2017)
Figure Africa Anticoagulants Sales Market Share by Type in 2016
Table Africa Anticoagulants Sales (Units) by Application (2012-2017)
Table Africa Anticoagulants Sales Market Share by Application (2012-2017)
Figure Africa Anticoagulants Sales Market Share by Application (2012-2017)
Table Africa Anticoagulants Sales Volume (Units) by Countries (2012-2017)
Table Africa Anticoagulants Sales Market Share by Countries (2012-2017)
Figure Africa Anticoagulants Sales Market Share by Countries (2012-2017)
Figure Africa Anticoagulants Sales Market Share by Countries in 2016
Table Africa Anticoagulants Revenue (Million USD) by Countries (2012-2017)
Table Africa Anticoagulants Revenue Market Share by Countries (2012-2017)
Figure Africa Anticoagulants Revenue Market Share by Countries (2012-2017)
Figure Africa Anticoagulants Revenue Market Share by Countries in 2016
Figure South Africa Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Nigeria Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Egypt Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Algeria Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Table Sanofi Anticoagulants Basic Information List
Table Sanofi Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Sanofi Anticoagulants Sales Market Share in EMEA (2012-2017)
Figure Sanofi Anticoagulants Revenue Market Share in EMEA (2012-2017)
Table Bayer Anticoagulants Basic Information List
Table Bayer Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Bayer Anticoagulants Sales Market Share in EMEA (2012-2017)
Figure Bayer Anticoagulants Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim Anticoagulants Basic Information List
Table Boehringer Ingelheim Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim Anticoagulants Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim Anticoagulants Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Anticoagulants Basic Information List
Table Johnson & Johnson Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Anticoagulants Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Anticoagulants Revenue Market Share in EMEA (2012-2017)
Table Genentech (Roche) Anticoagulants Basic Information List
Table Genentech (Roche) Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Genentech (Roche) Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Genentech (Roche) Anticoagulants Sales Market Share in EMEA (2012-2017)
Figure Genentech (Roche) Anticoagulants Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Anticoagulants Basic Information List
Table AstraZeneca Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure AstraZeneca Anticoagulants Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Anticoagulants Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Anticoagulants Basic Information List
Table Bristol-Myers Squibb Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Anticoagulants Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb Anticoagulants Revenue Market Share in EMEA (2012-2017)
Table Aspen Anticoagulants Basic Information List
Table Aspen Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Aspen Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Aspen Anticoagulants Sales Market Share in EMEA (2012-2017)
Figure Aspen Anticoagulants Revenue Market Share in EMEA (2012-2017)
Table Lilly Anticoagulants Basic Information List
Table Lilly Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Lilly Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Lilly Anticoagulants Sales Market Share in EMEA (2012-2017)
Figure Lilly Anticoagulants Revenue Market Share in EMEA (2012-2017)
Table Otsuka Anticoagulants Basic Information List
Table Otsuka Anticoagulants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Otsuka Anticoagulants Sales (Units) and Growth Rate (2012-2017)
Figure Otsuka Anticoagulants Sales Market Share in EMEA (2012-2017)
Figure Otsuka Anticoagulants Revenue Market Share in EMEA (2012-2017)
Table Pfizer Anticoagulants Basic Information List
Table Daiichi Sankyo Anticoagulants Basic Information List
Table The Medicines Company Anticoagulants Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anticoagulants
Figure Manufacturing Process Analysis of Anticoagulants
Figure Anticoagulants Industrial Chain Analysis
Table Raw Materials Sources of Anticoagulants Major Manufacturers in 2016
Table Major Buyers of Anticoagulants
Table Distributors/Traders List
Figure EMEA Anticoagulants Sales (Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Anticoagulants Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Anticoagulants Price (K USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Anticoagulants Sales (Units) Forecast by Region (2017-2022)
Figure EMEA Anticoagulants Sales Market Share Forecast by Region (2017-2022)
Table EMEA Anticoagulants Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Anticoagulants Revenue Market Share Forecast by Region (2017-2022)
Table Europe Anticoagulants Sales (Units) Forecast by Countries (2017-2022)
Figure Europe Anticoagulants Sales Market Share Forecast by Countries (2017-2022)
Table Europe Anticoagulants Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Anticoagulants Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Anticoagulants Sales (Units) Forecast by Countries (2017-2022)
Figure Middle East Anticoagulants Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Anticoagulants Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Anticoagulants Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Anticoagulants Sales (Units) Forecast by Countries (2017-2022)
Figure Africa Anticoagulants Sales Market Share Forecast by Countries (2017-2022)
Table Africa Anticoagulants Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Anticoagulants Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Anticoagulants Sales (Units) Forecast by Type (2017-2022)
Figure EMEA Anticoagulants Sales Market Share Forecast by Type (2017-2022)
Table EMEA Anticoagulants Sales (Units) Forecast by Application (2017-2022)
Figure EMEA Anticoagulants Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources